Biomarkers in Alzheimer disease: are we there yet?

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

(2020) Elisabeth H. Thijssen et al.   NATURE MEDICINE

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

(2020) Shorena Janelidze et al.   Nature Communications

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

(2019) Niklas Mattsson et al.   JAMA Neurology

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer’s disease

(2019) Tatiana Barichello et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology

(2018) Åsa Sandelius et al.   Alzheimers & Dementia

Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease

(2014) Natalia Salvadores et al.   Cell Reports